176 related articles for article (PubMed ID: 22693541)
1. The influence of HLA on HIV-associated neurocognitive impairment in Anhui, China.
Schrier RD; Gupta S; Riggs P; Cysique LA; Letendre S; Jin H; Spector SA; Singh KK; Wolfson T; Wu Z; Hong KX; Yu X; Shi C; Heaton RK;
PLoS One; 2012; 7(5):e32303. PubMed ID: 22693541
[TBL] [Abstract][Full Text] [Related]
2. Neurocognitive impairment in HIV-infected naïve patients with advanced disease: the role of virus and intrathecal immune activation.
Airoldi M; Bandera A; Trabattoni D; Tagliabue B; Arosio B; Soria A; Rainone V; Lapadula G; Annoni G; Clerici M; Gori A
Clin Dev Immunol; 2012; 2012():467154. PubMed ID: 22489249
[TBL] [Abstract][Full Text] [Related]
3. [T-lymphocyte immune in HIV-infected people and AIDS patients in China].
Li T; Qiu Z; Wang A; Sheng R
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1391-5. PubMed ID: 12509921
[TBL] [Abstract][Full Text] [Related]
4. Virologically suppressed patients with asymptomatic and symptomatic HIV-associated neurocognitive disorders do not display the same pattern of immune activation.
Vassallo M; Durant J; Lebrun-Frenay C; Fabre R; Ticchioni M; Andersen S; DeSalvador F; Harvey-Langton A; Dunais B; Cohen-Codar I; Montagne N; Cua E; Fredouille-Heripret L; Laffon M; Cottalorda J; Dellamonica P; Pradier C
HIV Med; 2015 Aug; 16(7):431-40. PubMed ID: 25981452
[TBL] [Abstract][Full Text] [Related]
5. Possession of HLA class II DRB1*1303 associates with reduced viral loads in chronic HIV-1 clade C and B infection.
Julg B; Moodley ES; Qi Y; Ramduth D; Reddy S; Mncube Z; Gao X; Goulder PJ; Detels R; Ndung'u T; Walker BD; Carrington M
J Infect Dis; 2011 Mar; 203(6):803-9. PubMed ID: 21257739
[TBL] [Abstract][Full Text] [Related]
6. CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy.
Ellis RJ; Badiee J; Vaida F; Letendre S; Heaton RK; Clifford D; Collier AC; Gelman B; McArthur J; Morgello S; McCutchan JA; Grant I;
AIDS; 2011 Sep; 25(14):1747-51. PubMed ID: 21750419
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid (CSF) CD8+ T-cells that express interferon-gamma contribute to HIV associated neurocognitive disorders (HAND).
Schrier RD; Hong S; Crescini M; Ellis R; Pérez-Santiago J; Spina C; Letendre S;
PLoS One; 2015; 10(2):e0116526. PubMed ID: 25719800
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Analysis of CD4
Hyun YS; Jo HA; Lee YH; Kim SM; Baek IC; Sohn HJ; Cho HI; Kim TG
Front Immunol; 2020; 11():602014. PubMed ID: 33658991
[TBL] [Abstract][Full Text] [Related]
9. APOE epsilon4 and MBL-2 O/O genotypes are associated with neurocognitive impairment in HIV-infected plasma donors.
Spector SA; Singh KK; Gupta S; Cystique LA; Jin H; Letendre S; Schrier R; Wu Z; Hong KX; Yu X; Shi C; Heaton RK;
AIDS; 2010 Jun; 24(10):1471-9. PubMed ID: 20442634
[TBL] [Abstract][Full Text] [Related]
10. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
[TBL] [Abstract][Full Text] [Related]
11. HLA class I associations with rates of HIV-1 seroconversion and disease progression in the Pumwani Sex Worker Cohort.
Peterson TA; Kimani J; Wachihi C; Bielawny T; Mendoza L; Thavaneswaran S; Narayansingh MJ; Kariri T; Liang B; Ball TB; Ngugi EN; Plummer FA; Luo M
Tissue Antigens; 2013 Feb; 81(2):93-107. PubMed ID: 23330720
[TBL] [Abstract][Full Text] [Related]
12. Possession of human leucocyte antigen DQ6 alleles and the rate of CD4 T-cell decline in human immunodeficiency virus-1 infection.
Vyakarnam A; Sidebottom D; Murad S; Underhill JA; Easterbrook PJ; Dalgleish AG; Peakman M
Immunology; 2004 May; 112(1):136-42. PubMed ID: 15096192
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic analysis of CD8+ T lymphocytes in a cohort of HIV type 1-infected patients treated with saquinavir, ritonavir, and two nucleoside analogs for 1 year, and association with plasma HIV type 1 RNA.
Kaufmann GR; Zaunders JJ; Cunningham P; Cooper DA
AIDS Res Hum Retroviruses; 1999 Jul; 15(11):963-72. PubMed ID: 10445808
[TBL] [Abstract][Full Text] [Related]
14. HLA-B*44 is associated with a lower viral set point and slow CD4 decline in a cohort of Chinese homosexual men acutely infected with HIV-1.
Zhang X; Huang X; Xia W; Li W; Zhang T; Wu H; Xu X; Yan H
Clin Vaccine Immunol; 2013 Jul; 20(7):1048-54. PubMed ID: 23677320
[TBL] [Abstract][Full Text] [Related]
15. HLA-DR-restricted peptides identified in the Nef protein can induce HIV type 1-specific IL-2/IFN-gamma-secreting CD4+ and CD4+ /CD8+ T cells in humans after lipopeptide vaccination.
Gahery H; Figueiredo S; Texier C; Pouvelle-Moratille S; Ourth L; Igea C; Surenaud M; Guillet JG; Maillere B
AIDS Res Hum Retroviruses; 2007 Mar; 23(3):427-37. PubMed ID: 17411376
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders.
Morgan EE; Woods SP; Letendre SL; Franklin DR; Bloss C; Goate A; Heaton RK; Collier AC; Marra CM; Gelman BB; McArthur JC; Morgello S; Simpson DM; McCutchan JA; Ellis RJ; Abramson I; Gamst A; Fennema-Notestine C; Smith DM; Grant I; Vaida F; Clifford DB;
J Neurovirol; 2013 Apr; 19(2):150-6. PubMed ID: 23408335
[TBL] [Abstract][Full Text] [Related]
17. APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study.
Cysique LA; Hewitt T; Croitoru-Lamoury J; Taddei K; Martins RN; Chew CS; Davies NN; Price P; Brew BJ
BMC Neurol; 2015 Apr; 15():51. PubMed ID: 25880550
[TBL] [Abstract][Full Text] [Related]
18. [The correlation between HLA-DR or CD38 expression in CD8(+)T cells and CD4(+)T cells count in treatment-naive HIV/AIDS patients].
Xie J; Qiu Z; Han Y; Li Y; Song X; Li T
Zhonghua Nei Ke Za Zhi; 2016 Jan; 55(1):36-9. PubMed ID: 26796651
[TBL] [Abstract][Full Text] [Related]
19. Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study.
Bisset LR; Cone RW; Huber W; Battegay M; Vernazza PL; Weber R; Grob PJ; Opravil M
AIDS; 1998 Nov; 12(16):2115-23. PubMed ID: 9833852
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Cellular Immune Responses in Thai Individuals With and Without HIV-Associated Neurocognitive Disorders.
Ratto-Kim S; Schuetz A; Sithinamsuwan P; Barber J; Hutchings N; Lerdlum S; Fletcher JLK; Phuang-Ngern Y; Chuenarom W; Tipsuk S; Pothisri M; Jadwattanakul T; Jirajariyavej S; Sajjaweerawan C; Akapirat S; Chalermchai T; Suttichom D; Kaewboon B; Prueksakaew P; Karnsomlap P; Clifford D; Paul RH; de Souza MS; Kim JH; Ananworanich J; Valcour V
AIDS Res Hum Retroviruses; 2018 Aug; 34(8):685-689. PubMed ID: 29737194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
